Powering the AI era of privacy-first healthcare commercialization to drive real-world outcomes.
Location: United States
Total raised: $26M
Investors 1
| Date | Name | Website |
| 04.07.2025 | Swift Vent... | swift.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.05.2026 | Series A | $26M | FCA Ventur... |
Mentions in press and media 12
| Date | Title | Description |
| 14.05.2026 | BranchLab Secures $26M Series A: AI Transforms Pharma Commercialization | BranchLab finalized a $26 million Series A funding round. McKesson Ventures led the investment, boosting total funding to $35 million. This capital propels BranchLab’s advanced AI platform. It revolutionizes pharmaceutical commercialization... |
| 13.05.2026 | BranchLab Raises $26M in Series A Funding | BranchLab, a Boulder, CO-based provider of an AI platform supporting healthcare commercialization, raised $26M in Series A funding. The round was led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and A... |
| 13.05.2026 | QuartzBio Receives Growth Investment from Eir Partners | QuartzBio, a Baltimore, MD-based life science technology company delivering portfolio‑scale sample and biomarker intelligence for clinical‑stage biopharma, received a growth investment form Eir Partners. The amount of the deal was not discl... |
| 13.05.2026 | BranchLab: $26 Million Series A Raised To Expand AI Platform For Pharma Commercialization | BranchLab announced a $26 million Series A financing round led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures. The financing brings the company’s total funding to $35 million. The compa... |
| 13.05.2026 | BranchLab raises $26M to transform pharma commercialization with privacy-first AI | Drugmakers sit on mountains of patient and healthcare data. The problem has never been a lack of access to information. The problem is speed. Marketing, audience targeting, patient outreach, and campaign measurement inside the pharmaceutica... |
| 13.05.2026 | BranchLab Scores $26M Series A | BOULDER, CO, BranchLab, an AI platform transforming how pharmaceutical companies commercialize therapies, announced a $26 million Series A financing. >> Click here for more funding data on BranchLab >> To export BranchLab fundi... |
| 09.09.2025 | Next Ventures Invests in BranchLab to Drive AI in Precision Healthcare | Next Ventures, a venture capital firm dedicated to advancing whole-person health, today announced a strategic investment in BranchLab, a provider of AI-native solutions for healthcare marketing. The investment underscores Next Ventures’ com... |
| 08.09.2025 | BranchLab Receives Investment from Next Ventures | BranchLab, a NYC-based provider of AI-native solutions for healthcare marketing, received an investment from Next Ventures. The amount of the deal was not disclosed. The company intends to use the funds to expand operations and its developm... |
| 18.07.2024 | Causal IQ Launches Groundbreaking 'ID-less' Healthcare Audience Solution | In Partnership with BranchLab, Causal IQ Introduces a Revolutionary Privacy-Focused Approach to Healthcare Advertising LOS ANGELES, July 18, 2024 /PRNewswire/ -- Causal IQ, a leading provider of advanced digital advertising solutions, annou... |
| 18.07.2024 | Causal IQ Launches ‘ID-less’ Healthcare Audience Solution | Causal IQ, a leading provider of advanced digital advertising solutions, announces the launch of its innovative ‘ID-less’ healthcare audience solution. This novel healthcare advertising solution leverages a strategic partnership with Branch... |
Show more